By expenditures
| Name | Title | Type |
|---|---|---|
| Gerald Milligan | Chief Financial Officer | Auditee |
| Adrian Jamieson | Executive Director / CEO | Auditee |
| Jeanna Jones | Audit Shareholder | Auditee |
| Cami Demaree | Principal, Non-Profits And Employee Benefits Plans | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 366061 | 2025 | 2025-09-11 | Comer Nowling and Associates PC | $8.37M |
| 340424 | 2024 | 2025-01-29 | Comer Nowling & Associates PC | $6.22M |
| 320514 | 2023 | 2024-09-24 | Lbmc PC | $6.47M |
| 295450 | 2022 | 2024-03-18 | Strothman and Company Psc | $8.95M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 366061 | 2025 | 2025-09-11 | 1152598 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 1152597 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 1152596 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 1152595 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 1152594 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 1152593 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 1152592 | 2025-005 | Material Weakness | Yes | L |
| 366061 | 2025 | 2025-09-11 | 1152591 | 2025-005 | Material Weakness | Yes | L |
| 366061 | 2025 | 2025-09-11 | 1152590 | 2025-004 | Material Weakness | - | F |
| 366061 | 2025 | 2025-09-11 | 1152589 | 2025-004 | Material Weakness | - | F |
| 366061 | 2025 | 2025-09-11 | 1152588 | 2025-003 | Significant Deficiency | - | C |
| 366061 | 2025 | 2025-09-11 | 1152587 | 2025-003 | Significant Deficiency | - | C |
| 366061 | 2025 | 2025-09-11 | 576156 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 576155 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 576154 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 576153 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 576152 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 576151 | 2025-006 | Significant Deficiency | - | L |
| 366061 | 2025 | 2025-09-11 | 576150 | 2025-005 | Material Weakness | Yes | L |
| 366061 | 2025 | 2025-09-11 | 576149 | 2025-005 | Material Weakness | Yes | L |
| 366061 | 2025 | 2025-09-11 | 576148 | 2025-004 | Material Weakness | - | F |
| 366061 | 2025 | 2025-09-11 | 576147 | 2025-004 | Material Weakness | - | F |
| 366061 | 2025 | 2025-09-11 | 576146 | 2025-003 | Significant Deficiency | - | C |
| 366061 | 2025 | 2025-09-11 | 576145 | 2025-003 | Significant Deficiency | - | C |
| 340424 | 2024 | 2025-01-29 | 1097141 | 2024-004 | Significant Deficiency | - | E |
| 340424 | 2024 | 2025-01-29 | 1097140 | 2024-005 | Material Weakness | - | L |
| 340424 | 2024 | 2025-01-29 | 1097139 | 2024-005 | Material Weakness | - | L |
| 340424 | 2024 | 2025-01-29 | 520699 | 2024-004 | Significant Deficiency | - | E |
| 340424 | 2024 | 2025-01-29 | 520698 | 2024-005 | Material Weakness | - | L |
| 340424 | 2024 | 2025-01-29 | 520697 | 2024-005 | Material Weakness | - | L |